See more : Kaspien Holdings Inc. (KSPN) Income Statement Analysis – Financial Results
Complete financial analysis of WayPoint Biomedical Holdings, Inc. (WYPH) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of WayPoint Biomedical Holdings, Inc., a leading company in the Shell Companies industry within the Financial Services sector.
- Glen Burnie Bancorp (GLBZ) Income Statement Analysis – Financial Results
- Trimurthi Limited (TRIMURTHI.BO) Income Statement Analysis – Financial Results
- Mainstreet Equity Corp. (MEQ.TO) Income Statement Analysis – Financial Results
- WOW WORLD Inc. (2352.T) Income Statement Analysis – Financial Results
- Gujchem Distillers India Limited (GUJCMDS.BO) Income Statement Analysis – Financial Results
WayPoint Biomedical Holdings, Inc. (WYPH)
Industry: Shell Companies
Sector: Financial Services
About WayPoint Biomedical Holdings, Inc.
WayPoint Biomedical Holdings, Inc., through its wholly owned subsidiary, WayPoint Biomedical, Inc., engages in the development and marketing of diagnostic tests and devices for screening and monitoring human health, fitness, and environment. It offers a drink spiking test, the Drink Detective, used to detect date rape drugs, including Ketamine, GHB, and Benzodiazapines; and Health Essist tests for cocaine and marijuana detection. The company also develops and commercializes test kits for detection against possible explosive devices, biowarfare/bioterrorism agents, and the detection of weapons of mass destruction. In addition, it provides Frontline Explosive Test Kit for the detection of explosive residues. The company offers its products to the over-the-counter diagnostic self-testing, the diagnostic point of care, and the homeland security and defense markets. WayPoint Biomedical Holdings was founded in 2004 and is based in Huntington Beach, California.
Source: https://incomestatements.info
Category: Stock Reports